human | Q5 |
P496 | ORCID iD | 0000-0001-5921-7368 |
0000-0002-9808-7970 | ||
P1153 | Scopus author ID | 7005952042 |
P69 | educated at | University of Sassari | Q532822 |
P108 | employer | Sapienza University of Rome | Q209344 |
Faculty of Medicine and Psychology, Sapienza University of Rome | Q45135477 | ||
P735 | given name | Speranza | Q3966508 |
Speranza | Q3966508 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q38656292 | A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat. |
Q37209940 | A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort. |
Q61783469 | A Survey on Blood Pressure Levels and Hypertension Control in a Sample of the Italian General Population |
Q46385948 | A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines |
Q59622852 | A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians |
Q59622860 | A role of TNF-alpha gene variant on juvenile ischemic stroke: a case-control study |
Q70489199 | Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure |
Q48402388 | Altered regulation of endothelin A receptor subtype in the cerebral arterioles in response to a Japanese-style diet, in stroke-prone hypertensive rats |
Q73175866 | Altered structure, regulation, and function of the gene encoding the atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat |
Q59380044 | Aminoterminal natriuretic peptide as a determinant of PAI-1 levels in a sample of the adult male Italian population |
Q51050321 | An easy and reproducible parameter for the assessment of the pressure gradient in patients with aortic stenosis disease: A magnetic resonance study. |
Q38534772 | Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy. |
Q70526618 | Angiotensin II directly stimulates release of atrial natriuretic factor in isolated rabbit hearts |
Q67593276 | Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure |
Q37357298 | Association and cosegregation of stroke with impaired endothelium-dependent vasorelaxation in stroke prone, spontaneously hypertensive rats. |
Q48369215 | Association of a single nucleotide polymorphism of the NPR3 gene promoter with early onset ischemic stroke in an Italian cohort |
Q48459991 | Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. |
Q37195866 | Atrial natriuretic Peptide single nucleotide polymorphisms in patients with nonfamilial structural atrial fibrillation |
Q59622853 | Atrial natriuretic peptide (ANP) gene promoter variant and increased susceptibility to early development of hypertension in humans |
Q38092606 | Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies |
Q28250065 | Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans |
Q61783490 | Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles |
Q33812913 | C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP. |
Q38316737 | C2238 atrial natriuretic peptide molecular variant is associated with endothelial damage and dysfunction through natriuretic peptide receptor C signaling. |
Q43076955 | C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro |
Q91317685 | Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art |
Q37901662 | Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases. |
Q46332264 | Common genetic variants in selected Ca²⁺ signaling genes and the risk of appropriate ICD interventions in patients with heart failure. |
Q53923149 | Contribution of genetic factors to renal lesions in the stroke-prone spontaneously hypertensive rat. |
Q61783487 | Correspondence |
Q61783484 | Defective suppression of the aldosterone biosynthesis during stroke permissive diet in the stroke-prone phenotype of the spontaneously hypertensive rat |
Q43068711 | Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy. |
Q42316713 | Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway |
Q45971592 | Differential modulation of uncoupling protein 2 in kidneys of stroke-prone spontaneously hypertensive rats under high-salt/low-potassium diet. |
Q50112681 | Early-onset ischaemic stroke: analysis of 58 polymorphisms in 17 genes involved in methionine metabolism |
Q42165161 | Effect of a regulatory mutation on the rat atrial natriuretic peptide gene transcription. |
Q54188881 | Effects of one-year treatment with rilmenidine on systemic hypertension-induced left ventricular hypertrophy in hypertensive patients |
Q96580482 | Epigenetic control of natriuretic peptides: implications for health and disease |
Q72050842 | Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy |
Q34065857 | Etiology and pathophysiology of stroke as a complex trait |
Q61783471 | Evaluation of Systolic Properties in Hypertensive Patients With Different Degrees of Diastolic Dysfunction and Normal Ejection Fraction |
Q58464204 | Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy |
Q34207430 | Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure |
Q40742874 | Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. |
Q59622864 | Gene polymorphisms of the renin???angiotensin???aldosterone system and the risk of ischemic stroke |
Q48502714 | High natriuretic peptide levels and low DBP: companion markers of cardiovascular risk? |
Q68034026 | Highest concentrations of prorenin and human chorionic gonadotropin in gestational sacs during early human pregnancy |
Q48730177 | Human coronary atherosclerosis modulates cardiac natriuretic peptide release. |
Q36035785 | Hypertension and heart failure: role of neurohormonal mechanisms |
Q38117232 | Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage |
Q49141329 | Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol |
Q48492870 | Impaired vasorelaxant responses to natriuretic peptides in the stroke-prone phenotype of spontaneously hypertensive rats |
Q35642921 | In the search for stroke genes: a long and winding road |
Q70492690 | Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats |
Q73595845 | Intrarenal determinants of sodium retention in mild heart failure: effects of angiotensin-converting enzyme inhibition |
Q61783475 | Markers of Inflammation and Fibrosis Are Related to Cardiovascular Damage in Hypertensive Patients with Metabolic Syndrome |
Q28077854 | Mitochondrial Dysfunction Contributes to Hypertensive Target Organ Damage: Lessons from an Animal Model of Human Disease |
Q67898757 | Modulatory role of angiotensin-II in the secretion of atrial natriuretic factor in rabbits |
Q42666163 | Molecular cloning and expression of rat kallistatin gene |
Q37914058 | Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides. |
Q37766468 | NPR-C: a component of the natriuretic peptide family with implications in human diseases. |
Q40847969 | NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation |
Q55055397 | NT-proANP circulating level is a prognostic marker in stable ischemic heart disease. |
Q59624975 | NT-proANP/ANP is a Determinant of Vascular Damage in Humans |
Q44214089 | NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis. |
Q37626852 | Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications |
Q31126960 | Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis |
Q38162429 | Natriuretic peptides in cardiovascular diseases: current use and perspectives |
Q37157505 | Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. |
Q28578344 | Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease |
Q26865574 | New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart |
Q57549294 | No association between chromosome 12p13 single nucleotide polymorphisms and early-onset ischemic stroke |
Q38165049 | Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? |
Q27015633 | Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress |
Q24600189 | Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians |
Q26778562 | Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art |
Q59622861 | Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population |
Q38184967 | Polypharmacy in heart failure patients. |
Q42799896 | Prediction of long-term survival in chronic heart failure by multiple biomarker assessment: a 15-year prospective follow-up study |
Q54282390 | Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARα/UCP2 axis |
Q61783467 | Pulmonary embolism in pregnancy |
Q43287306 | Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro. |
Q48474397 | Reciprocal congenic lines for a major stroke QTL on rat chromosome 1. |
Q41084345 | Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat. |
Q61783477 | Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass |
Q72331322 | Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats |
Q44052509 | Relation between urinary kallikrein excretion and blood pressure response to a single oral dose of captopril |
Q37991856 | Renin as a biomarker of cardiovascular disease in clinical practice. |
Q38854043 | Resetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HF |
Q100388307 | Role of DAMPs and of Leukocytes Infiltration in Ischemic Stroke: Insights from Animal Models and Translation to the Human Disease |
Q60647401 | Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells |
Q61783486 | Role of angiotensin II AT 1 and AT 2 subtype receptors in the regulation of atrial natriuretic peptide expression in salt-restricted rats |
Q35918412 | Role of genetic factors in the etiopathogenesis of cerebrovascular accidents: from an animal model to the human disease. |
Q37387706 | Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. |
Q73833066 | Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of nephrectomized rats |
Q53291322 | RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure |
Q44077525 | Short-term efficacy of nifedipine in essential and renovascular hypertension. |
Q41727852 | T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients. |
Q50055077 | T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients. |
Q35425744 | The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells |
Q48284904 | The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. |
Q56985191 | The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes |
Q73092438 | The gene encoding atrial natriuretic peptide and the risk of human stroke |
Q91941818 | The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome |
Q68252366 | Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid |
Q44903311 | Trypsin activation of human and cat prorenin: a comparative study. |
Q59622854 | β2-Adrenergic Receptor Gene Polymorphisms and Risk of Ischemic Stroke |
Search more.